Trial intelligence / Profile preview

Dasatinib compassionate use in CML and Philadelphia-positive ALL

2006-003581-34Phase 3Completed

Sponsor

IRCCS Ospedale San Raffaele

Start

Mar 2007

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1